Central Pacific Bank - Trust Division’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156K Sell
1,545
-20
-1% -$2.07K 0.02% 528
2026
Q1
$151K Sell
1,565
-654
-29% -$67.1K 0.02% 515
2025
Q4
$236K Buy
2,219
+157
+8% +$18.2K 0.03% 409
2025
Q3
$262K Sell
2,062
-282
-12% -$33.6K 0.03% 392
2025
Q2
$287K Sell
2,344
-918
-28% -$105K 0.04% 366
2025
Q1
$330K Buy
3,262
+67
+2% +$6.54K 0.05% 342
2024
Q4
$295K Buy
3,195
+418
+15% +$41K 0.04% 375
2024
Q3
$268K Buy
2,777
+657
+31% +$59K 0.03% 405
2024
Q2
$182K Sell
2,120
-210
-9% -$17.6K 0.02% 564
2024
Q1
$194K Buy
+2,330
New +$171K 0.02% 547

Other funds holding EHC

Central Pacific Bank - Trust Division's EHC Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its Encompass Health (EHC) stake by 1.3% in Q2 2026, selling an estimated $2.07K and leaving 1,545 shares worth $156K. The position accounts for 0.02% of the portfolio, ranked #528.

Central Pacific Bank - Trust Division first reported a position in EHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $330K in Q1 2025. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Central Pacific Bank - Trust Division held 1,545 shares of Encompass Health worth $156K as of Q2 2026.
  • Central Pacific Bank - Trust Division sold 20 Encompass Health shares in Q2 2026, an estimated $2.07K.
  • Encompass Health made up 0.02% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #528 holding.
  • Central Pacific Bank - Trust Division first reported a position in Encompass Health in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Encompass Health position peaked at $330K in Q1 2025.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.